UnknownNCT01346150
Patients Treated for SCID (1968-Present)
Studying T-B+ severe combined immunodeficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Principal Investigator
- Elie Haddad, MD, PhDUniversity of Montréal, CHU Sainte-Justine
- Enrollment
- 1007 enrolled
- Eligibility
- All sexes
- Timeline
- 2011 – 2023
Study locations (30)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- Children's Hospital Los Angeles, Los Angeles, California, United States
- Mattel Children's Hospital UCLA: Division of Pediatric Hematology/Oncology, Los Angeles, California, United States
- Lucile Salter Packard Children's Hospital at Stanford, Palo Alto, California, United States
- University of California San Francisco Children's Hospital, San Francisco, California, United States
- Children's Hospital Denver:Center for Cancer and Blood Disorders, Denver, Colorado, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Johns Hopkins All Children's Hospital, St. Petersburg, Florida, United States
- Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, Georgia, United States
- Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
- Children's Hospital/Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States
- NIH Clinical Center Genetic Immunotherapy Section, Bethesda, Maryland, United States
- Children's Hospital Boston, Boston, Massachusetts, United States
- University of Michigan Health System, Ann Arbor, Michigan, United States
- University of Minnesota Medical Center, Minneapolis, Minnesota, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Primary Immune Deficiency Treatment Consortium (PIDTC) · National Center for Advancing Translational Sciences (NCATS)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01346150 on ClinicalTrials.govOther trials for T-B+ severe combined immunodeficiency
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONPHASE1, PHASE2NCT06851767Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene TherapyNational Institute of Allergy and Infectious Diseases (NIAID)
- ACTIVE NOT RECRUITINGPHASE2NCT03619551Conditioning SCID Infants Diagnosed EarlyCenter for International Blood and Marrow Transplant Research
- RECRUITINGPHASE1, PHASE2NCT01306019Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)National Institute of Allergy and Infectious Diseases (NIAID)